Related Experiment Video
Updated: Jul 19, 2026
08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
SiRNA drug delivery by biodegradable polymeric nanoparticles
Xudong Yuan1, Ling Li, Appu Rathinavelu
1Division of Pharmaceutical Sciences, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, 75 Dekalb Avenue, NY 11201, USA.
Journal of Nanoscience and Nanotechnology
|October 20, 2006
Summary
Biodegradable nanoparticles effectively deliver small interfering RNA (siRNA) for gene silencing. This novel drug delivery system shows promise for future clinical applications in siRNA therapeutics.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Biology
Background:
- RNA interference (RNAi) utilizes double-stranded RNA (dsRNA) to degrade complementary mRNA.
- Small interfering RNA (siRNA) shows therapeutic potential, but effective drug delivery remains a challenge.
- Biodegradable polymers offer a promising platform for novel drug delivery systems.
Purpose of the Study:
- To develop and characterize a biodegradable poly(D,L-lactide-co-glycolide) (PLGA) nanoparticle system for siRNA delivery.
- To evaluate the efficiency of siRNA loading and cellular uptake of the PLGA nanoparticles.
- To assess the gene silencing efficacy of siRNA delivered via PLGA nanoparticles.
Main Methods:
- Preparation and characterization of PLGA nanoparticles using scanning electron microscopy and laser diffraction.
- Delivery of fluorescently labeled siRNA (Cy3-oligos) into 293T cells.
- Assessment of gene silencing using fluorescent microscopy to observe GFP expression inhibition by si-GFP-RNA loaded nanoparticles.
Main Results:
- PLGA nanoparticles were successfully prepared with desired physicochemical properties.
- Effective delivery and cellular uptake of siRNA into targeted 293T cells were confirmed.
- Significant GFP gene silencing was observed, demonstrating the efficacy of the siRNA-loaded nanoparticles.
Conclusions:
- Biodegradable PLGA nanoparticles provide an effective system for siRNA drug delivery.
- This nanoparticle system demonstrates prominent gene silencing capabilities.
- The improved formulation stability offers practical benefits for potential clinical translation of siRNA therapeutics.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...